139 related articles for article (PubMed ID: 14687619)
1. All three receptors for vascular endothelial growth factor (VEGF) are expressed on B-chronic lymphocytic leukemia (CLL) cells.
Bairey O; Boycov O; Kaganovsky E; Zimra Y; Shaklai M; Rabizadeh E
Leuk Res; 2004 Mar; 28(3):243-8. PubMed ID: 14687619
[TBL] [Abstract][Full Text] [Related]
2. VEGF receptors on chronic lymphocytic leukemia (CLL) B cells interact with STAT 1 and 3: implication for apoptosis resistance.
Lee YK; Shanafelt TD; Bone ND; Strege AK; Jelinek DF; Kay NE
Leukemia; 2005 Apr; 19(4):513-23. PubMed ID: 15703780
[TBL] [Abstract][Full Text] [Related]
3. Circulating vascular endothelial growth factor (VEGF) and its soluble receptors in patients with chronic lymphocytic leukemia.
Gora-Tybor J; Blonski JZ; Robak T
Eur Cytokine Netw; 2005; 16(1):41-6. PubMed ID: 15809205
[TBL] [Abstract][Full Text] [Related]
4. B-CLL cells are capable of synthesis and secretion of both pro- and anti-angiogenic molecules.
Kay NE; Bone ND; Tschumper RC; Howell KH; Geyer SM; Dewald GW; Hanson CA; Jelinek DF
Leukemia; 2002 May; 16(5):911-9. PubMed ID: 11986954
[TBL] [Abstract][Full Text] [Related]
5. VEGF receptor phosphorylation status and apoptosis is modulated by a green tea component, epigallocatechin-3-gallate (EGCG), in B-cell chronic lymphocytic leukemia.
Lee YK; Bone ND; Strege AK; Shanafelt TD; Jelinek DF; Kay NE
Blood; 2004 Aug; 104(3):788-94. PubMed ID: 14996703
[TBL] [Abstract][Full Text] [Related]
6. Malignant hematopoietic cells induce an increased expression of VEGFR-1 and VEGFR-3 on bone marrow endothelial cells via AKT and mTOR signalling pathways.
Mirshahi P; Toprak SK; Faussat AM; Dubrulle S; Marie JP; Soria C; Soria J; Mirshahi M
Biochem Biophys Res Commun; 2006 Oct; 349(3):1003-10. PubMed ID: 16959214
[TBL] [Abstract][Full Text] [Related]
7. Lysophosphatidic acid receptor expression in chronic lymphocytic leukemia leads to cell survival mediated though vascular endothelial growth factor expression.
Kumar SA; Hu X; Brown M; Kuschak B; Hernandez TA; Johnston JB; Gibson SB
Leuk Lymphoma; 2009 Dec; 50(12):2038-48. PubMed ID: 19860625
[TBL] [Abstract][Full Text] [Related]
8. Autocrine VEGF mediates the antiapoptotic effect of CD154 on CLL cells.
Farahani M; Treweeke AT; Toh CH; Till KJ; Harris RJ; Cawley JC; Zuzel M; Chen H
Leukemia; 2005 Apr; 19(4):524-30. PubMed ID: 15674425
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor-C promotes the growth and invasion of gallbladder cancer via an autocrine mechanism.
Chen Y; Jiang L; She F; Tang N; Wang X; Li X; Han S; Zhu J
Mol Cell Biochem; 2010 Dec; 345(1-2):77-89. PubMed ID: 20734221
[TBL] [Abstract][Full Text] [Related]
10. The angiogenic status of B-CLL B cells: role of the VEGF receptors.
Kay NE
Leuk Res; 2004 Mar; 28(3):221-2. PubMed ID: 14687614
[No Abstract] [Full Text] [Related]
11. Immature B cell malignancies synthesize VEGF, VEGFR-1 (Flt-1) and VEGFR-2 (KDR).
El-Obeid A; Sunnuqrut N; Hussain A; Al-Hussein K; GutiƩrrez MI; Bhatia K
Leuk Res; 2004 Feb; 28(2):133-7. PubMed ID: 14654077
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of both paracrine and autocrine VEGF/ VEGFR-2 signaling pathways is essential to induce long-term remission of xenotransplanted human leukemias.
Dias S; Hattori K; Heissig B; Zhu Z; Wu Y; Witte L; Hicklin DJ; Tateno M; Bohlen P; Moore MA; Rafii S
Proc Natl Acad Sci U S A; 2001 Sep; 98(19):10857-62. PubMed ID: 11553814
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow stromal cell-derived vascular endothelial growth factor (VEGF) rather than chronic lymphocytic leukemia (CLL) cell-derived VEGF is essential for the apoptotic resistance of cultured CLL cells.
Gehrke I; Gandhirajan RK; Poll-Wolbeck SJ; Hallek M; Kreuzer KA
Mol Med; 2011; 17(7-8):619-27. PubMed ID: 21519633
[TBL] [Abstract][Full Text] [Related]
14. CLL, but not normal, B cells are dependent on autocrine VEGF and alpha4beta1 integrin for chemokine-induced motility on and through endothelium.
Till KJ; Spiller DG; Harris RJ; Chen H; Zuzel M; Cawley JC
Blood; 2005 Jun; 105(12):4813-9. PubMed ID: 15731179
[TBL] [Abstract][Full Text] [Related]
15. Autocrine/paracrine involvement of insulin-like growth factor-I and its receptor in chronic lymphocytic leukaemia.
Schillaci R; Galeano A; Becu-Villalobos D; Spinelli O; Sapia S; Bezares RF
Br J Haematol; 2005 Jul; 130(1):58-66. PubMed ID: 15982345
[TBL] [Abstract][Full Text] [Related]
16. Autocrine and paracrine roles of VEGF/VEGFR-2 and VEGF-C/VEGFR-3 signaling in angiosarcomas of the scalp and face.
Tokuyama W; Mikami T; Masuzawa M; Okayasu I
Hum Pathol; 2010 Mar; 41(3):407-14. PubMed ID: 19913279
[TBL] [Abstract][Full Text] [Related]
17. Magnitude of stromal hemangiogenesis correlates with histologic subtype of non-Hodgkin's lymphoma.
Ruan J; Hyjek E; Kermani P; Christos PJ; Hooper AT; Coleman M; Hempstead B; Leonard JP; Chadburn A; Rafii S
Clin Cancer Res; 2006 Oct; 12(19):5622-31. PubMed ID: 17020964
[TBL] [Abstract][Full Text] [Related]
18. High levels of vascular endothelial growth factor receptor-2 correlate with shortened survival in chronic lymphocytic leukemia.
Ferrajoli A; Manshouri T; Estrov Z; Keating MJ; O'Brien S; Lerner S; Beran M; Kantarjian HM; Freireich EJ; Albitar M
Clin Cancer Res; 2001 Apr; 7(4):795-9. PubMed ID: 11309324
[TBL] [Abstract][Full Text] [Related]
19. Increased angiogenesis and expression of vascular endothelial growth factor during scarless repair.
Colwell AS; Beanes SR; Soo C; Dang C; Ting K; Longaker MT; Atkinson JB; Lorenz HP
Plast Reconstr Surg; 2005 Jan; 115(1):204-12. PubMed ID: 15622252
[TBL] [Abstract][Full Text] [Related]
20. Upregulated autocrine vascular endothelial growth factor (VEGF)/VEGF receptor-2 loop prevents apoptosis in haemangioma-derived endothelial cells.
Ji Y; Chen S; Li K; Xiao X; Xu T; Zheng S
Br J Dermatol; 2014 Jan; 170(1):78-86. PubMed ID: 24033364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]